MedTrace Logo

Efficacy and Safety of Tolvaptan in Japanese Patients With Acute Heart Failure

NCT01635517 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 274

Last updated 2017-06-02

No results posted yet for this study

Summary

The aims of the present study are to investigate prospectively the clinical course and outcome of the hospitalized heart failure patients treated with tolvaptan for management of fluid retention and serum sodium levels of less than 140 mEq/L and also to analyze the factors related with the efficacy including outcome of tolvaptan therapy.

Conditions

Sponsors & Collaborators

  • Nippon Medical School, Musashi Kosugi Hospital

    collaborator UNKNOWN

  • Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan

    lead OTHER

Principal Investigators

  • Naoki Sato, MD,PhD · Nippon Medical School, Musashi Kosugi Hospital

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-07-01
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • Japan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01635517 on ClinicalTrials.gov